Gruss & Co’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-100,000
| Closed | -$646K | – | 18 |
|
|
2023
Q2 | $646K | Sell |
100,000
-67,500
| -40% | -$436K | 3.92% | 12 |
|
|
2023
Q1 | $1.26M | Sell |
167,500
-87,900
| -34% | -$663K | 7.99% | 5 |
|
|
2022
Q4 | $2.59M | Sell |
255,400
-53,170
| -17% | -$539K | 15.98% | 1 |
|
|
2022
Q3 | $3.05M | Sell |
308,570
-55,208
| -15% | -$546K | 26.27% | 1 |
|
|
2022
Q2 | $3.87M | Buy |
363,778
+77,778
| +27% | +$828K | 26.99% | 1 |
|
|
2022
Q1 | $2.79M | Sell |
286,000
-140,966
| -33% | -$1.37M | 12.38% | 1 |
|
|
2021
Q4 | $6.11M | Sell |
426,966
-3,441
| -0.8% | -$49.2K | 16.39% | 1 |
|
|
2021
Q3 | $8.63M | Buy |
+430,407
| New | +$8.63M | 24.12% | 1 |
|